169 results
Page 3 of 9
8-K
EX-10.1
mykl70
22 Mar 21
Relief to potentially pay Acer up to $36 million and royalties in exchange for net profit share and territory rights
8:31am
8-K
EX-10.2
1hpzaeyovomdh451x
25 Jan 21
Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for the Treatment of
8:03am
8-K
EX-10.3
11fpjtpjam 6tmilg
25 Jan 21
Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for the Treatment of
8:03am
8-K
EX-10.1
4w5zuslwalm3
25 Jan 21
Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for the Treatment of
8:03am
8-K
EX-10.1
n0kz9bqiq
27 Jul 20
Entry into a Material Definitive Agreement
9:00am
8-K
EX-10.1
7sd710bg9vo3np
30 Apr 20
Acer Therapeutics Announces Common Stock Purchase Agreement for up to $15 million with Lincoln Park Capital
4:10pm
8-K
EX-10.2
uw5vko24c
30 Apr 20
Acer Therapeutics Announces Common Stock Purchase Agreement for up to $15 million with Lincoln Park Capital
4:10pm
8-K
EX-10.1
lsa7wu
9 Nov 18
Entry into a Material Definitive Agreement
4:25pm
8-K
EX-10.3
dhdbo7s l4h
15 May 18
Material Modifications to Rights of Security Holders
4:00pm